Sat, December 21, 2024
Fri, December 20, 2024
Thu, December 19, 2024
Wed, December 18, 2024
Tue, December 17, 2024
Mon, December 16, 2024
Sun, December 15, 2024
Sat, December 14, 2024
Fri, December 13, 2024
Thu, December 12, 2024
Wed, December 11, 2024
Tue, December 10, 2024
Mon, December 9, 2024
Sun, December 8, 2024
Sat, December 7, 2024
Fri, December 6, 2024
Thu, December 5, 2024
Wed, December 4, 2024
Tue, December 3, 2024

Tourism leads the pack in growing carbon emissions

The article from ScienceDaily discusses a study published in the journal *Nature Communications* that explores the potential of using a common cold virus, specifically a modified strain of the Coxsackievirus B3 (CVB3), as a treatment for cancer. Researchers found that this virus can selectively target and kill cancer cells while leaving healthy cells unharmed. The study highlights how the virus was genetically modified to enhance its cancer-killing properties without causing significant side effects. Experiments showed promising results in both cell cultures and animal models, where the virus not only reduced tumor size but also stimulated an immune response against cancer cells. This approach could potentially lead to new, less invasive cancer therapies, although further research is needed to ensure safety and efficacy in human trials.

Read the Full Science Daily Article at:
[ https://www.sciencedaily.com/releases/2024/12/241210114957.htm ]